VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for Keros Therapeutics Inc Common Stock (KROS)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Keros Therapeutics Inc Common Stock
Symbol: KROS
Shares outstanding: 30,507,100 shares
Disclosed Ownership: 1,525,355 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 30 Jan 2026, 14:17:14 UTC
Date of event: 31 Dec 2025
Previous filing: 30 Apr 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5%	1,525,355	0	146,965	Ashley Grim	Head of Global Fund Administration